Documentos relacionados

1. Immune modulation in chronic myeloid leukaemia patients treated with nilotinib and interferon-alpha.
2. Flow cytometry and targeted immune transcriptomics identify distinct profiles in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitors with or without interferon-α.
3. [Successful delivery using interferon α for molecular relapse of chronic myeloid leukemia after interruption of tyrosine kinase inhibitor].
4. Deep Molecular Response Achieved with Chemotherapy, Dasatinib and Interferon α in Patients with Lymphoid Blast Crisis of Chronic Myeloid Leukaemia.
5. Interferon in chronic myeloid leukaemia: Is it useful for treatment-free remission?
6. INVESTIGATION OF THE EFFECT OF SUDDEN HEARING LOSS ON VESTIBULAR TESTS.
7. Fertility Preservation in Leukemia.
8. Correlation of coagulation states with prognosis of sudden deafness.
9. Interferon-α Based Individualized Treatment of a High Risk Chronic Myelogenous Leukemia Patient Harboring T315I Mutation.
10. The efficacy of nurse-led hyperbaric oxygen therapy in improving the quality of life in patients with sudden hearing loss.